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http://dx.doi.org/10.1016/j.jmii.2014
1684-1182/Copyright ª 2014, TaiwanBackground/Purpose: Information concerning antibiotics susceptibilities of beta-hemolytic
group G Streptococcus dysgalactiae subspecies equisimilis (SDSE) clinical isolates in central
Taiwan was limited.
Methods: Totally, 246 SDSE isolates were collected from mainly five regional hospitals, from
February 2007 to August 2011. Disk diffusion method, broth microdilution method, and clinda-
mycin induction test (D test) were respectively performed according to the guidelines of the
Clinical and Laboratory Standards Institute. Polymerase chain reaction was used to detect
the corresponding erythromycin resistance genes.
Results: All isolates were susceptible to penicillin, cefotaxime, and vancomycin. The rate of
erythromycin resistance was 24.0% (59/246), whereas that of clindamycin resistance was
12.2% (30/246). The resistance rates of isolates from different hospitals varied from 15.0% to
45.5% for erythromycin and from 7.1% to 36.4% for clindamycin. For erythromycin-resistant
SDSE isolates, three different phenotypes with resistance to macrolides (M), lincosamides (L),
and type B streptogramins (SB) were observed: M (49.2%), constitutive MLSB (cMLSB, 35.6%),
and inducible MLSB (iMLSB, 15.3%). All M phenotypic isolates carried mefA. The most prevalent
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614 H.-H. Lo et al.isolate with cMLSB phenotype carried both ermB and ermTR, whereas one isolate with iMLSB
phenotype carried both ermB and ermC.
Conclusion: This is the first trial investigating the antimicrobial susceptibility pattern and
erythromycin resistance mechanisms of beta-hemolytic group G SDSE isolates in central Taiwan.
The resistance rates for both erythromycin and clindamycin varied significantly among hospitals
located in this area and should be monitored continuously in the future.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
The clinical importance of group G streptococci (GGS) is
increasing with incidence, with the occurrence of infection
caused by GGS being higher than that of either group A
Streptococcus or group B Streptococcus infection among
beta-hemolytic streptococci.1,2 Human GGS mainly include
the Streptococcus dysgalactiae subspecies equisimilis
(SDSE) and the Streptococcus anginosus group.3 Generally,
SDSE represents the most predominant species.4 Recently,
in a survey of beta-hemolytic GGS isolated in central
Taiwan, we found that 90.1% of GGS isolates belong to
SDSE.5 A broad spectrum of human diseases is associated
with SDSE, ranging from wild pharyngitis1 to life-threatening
streptococcal toxic shock syndrome.6
Penicillin is generally used to treat SDSE infection. In
addition to penicillin allergy, however, penicillin tolerance
[minimum bactericidal concentration/minimum inhibitory
concentration (MBC/MIC) ratio 32] in SDSE has been re-
ported.7 Meanwhile, disease recurrence is another problem
encountered while treating SDSE infection.8 In such cir-
cumstances, erythromycin can be used instead of beta-
lactam antibiotics. Considering that SDSE isolates may
display different susceptibility patterns, antibiotic suscep-
tibility tests should be performed to determine the proper
medical regimen.
Two major mechanisms of erythromycin resistance are
recognized in streptococci, including SDSE.9,10 Erythro-
mycin resistance methylase (encoded by erm) modifies
23S rRNA, leading to the coresistance toward lincosamide
and streptogramin B, which is defined as MLSB phenotype.
Two expression patterns can be observed: inducible and
constitutive MLSB (iMLSB and cMLSB). Isolates with cMLSB
phenotype constitutively express rRNA methylase and can
easily be detected by routine disk diffusion method. Iso-
lates with iMLSB phenotype produce methylase only in the
presence of an inducing agent (such as erythromycin), and
display erythromycin resistance and clindamycin suscepti-
bility, as evident from routine disk diffusion test. For the
detection of iMLSB phenotype, a special disk diffusion
method, the clindamycin induction test (D test), should be
used.11 The second mechanism, represented as M type,
involves an efflux pump (encoded by mef ) and shows no
cross-resistance to lincosamide and streptogramin B. The
difference in macrolide resistance mechanisms among
streptococci can affect the therapeutic strategy.12 For
example, Streptococcus pneumoniae with mefE genotype
generally has an erythromycin MIC of 2e16 mg/L13;however, isolates with the erm genotype have an MIC
higher than 128 mg/L.14 As azithromycin can be concen-
trated at the infection site, this antibiotic may treat mefE-
genotypic S. pneumonia infection, but not erm-genotypic
bacterial infection. Studies on antibiotic susceptibility
patterns and resistance mechanisms may not only be useful
for providing information on proper treatment, but also be
helpful in understanding the regional diversity in resistance
rates and the spread of resistance-associated genes.
Several surveys concerning antimicrobial resistance in
GGS have been conducted in northern Taiwan,15,16 but they
were rarely focused on SDSE or performed in central
Taiwan. Owing to the clinical significance of SDSE among
GGS, we examined 246 consecutive nonduplicate beta-
hemolytic SDSE isolates that were collected mainly from
five regional hospitals in central Taiwan. Antibiotic sus-
ceptibility pattern and erythromycin resistance mecha-
nisms were investigated to unclose this issue in this area.
Methods
Bacterial collection and molecular identification
We collected and stocked 246 consecutive nonduplicate
beta-hemolytic group G SDSE isolates mainly from facilities
located in central Taiwan, including the Central Laboratory
of the Central Region Hospital Alliance (Taichung, Taiwan)
and the Clinical Bacteriology Laboratory of Lin Shin Hospital
(Taichung, Taiwan), betweenFebruary2007andAugust2011,
using previously described procedures.5 Bacteria were iden-
tified using 16S rRNA gene sequencing.5 Among the 246 SDSE
isolates, 66 were from invasive infection sites, including
blood and other sterile body fluids, whereas 180 were from
noninvasive infection sites, including sputum, pus, urine,
throat, vaginal discharge, and the gastrointestinal tract.
Antibiotic susceptibility tests
We used the disk diffusion method to determine the sus-
ceptibility of SDSE isolates toward penicillin, vancomycin,
erythromycin, clindamycin, levofloxacin, and cefotaxime,
in accordance with the Clinical and Laboratory Standards
Institute guidelines.17 In addition, broth microdilution
method was applied to determine MIC of these antibiotics
among erythromycin-resistant isolates.17 The clindamycin
induction test (D test) was then used to detect isolates
with erythromycin-resistant and clindamycin-susceptible
Table 1 Antibiotic susceptibility patterns of 246 SDSE
isolates
Antibiotics No. of isolates (%)
Resistant Intermediate Susceptible
Penicillin 0 (0) 0 (0) 246 (100.0)
Vancomycin 0 (0) 0 (0) 246 (100.0)
Erythromycin 59 (24.0) 6 (2.3) 181 (73.6)
Clindamycin 30 (12.2)a 2 (0.8) 214 (87.0)
Cefotaxime db db 246 (100.0)
Levofloxacin 3 (1.2) 3 (1.2) 240 (97.6)
a Confirmed by D test.
b No interpretive criteria other than “susceptible”.
SDSE Z Streptococcus dysgalactiae subspecies equisimilis.
Table 2 Erythromycin and clindamycin resistance rates in
SDSE isolates from different hospitals
Source (no.) No. of resistant isolates (%)
Erythromycin Clindamycin
Taichung Hospital (45) 14 (31.1) 5 (11.1)
Fong Yuan Hospital (40) 13 (32.5) 9 (22.5)
Chang Hua Hospital (11) 5 (45.5) 4 (36.4)
Nantou Hospital (60) 9 (15.0) 6 (10.0)
Lin Shin Hospital (85) 17 (20.0) 6 (7.1)
Othersa (5) 1 (20.0) 0 (0.0)
Total 59 (24.0) 30 (12.2)
a Patient samples from some central Taiwan clinics.
SDSE Z Streptococcus dysgalactiae subspecies equisimilis.
Antibiograms and erythromycin resistance of SDSE isolates 615phenotypes.9,11 Briefly, Mu¨ller-Hinton agar supplemented
with sheep blood (5% v/v) was used to inoculate bacterial
suspension (adjusted to McFarland 0.5 turbidity). The 15-mg
erythromycin disk and 2-mg clindamycin disk were spaced
12 mm apart, and then the plate was placed in a 5% CO2
incubator at 37C for 20e24 hours. Isolates with iMLSB
phenotype have the feature of flattening of the inhibition
zone adjacent to the erythromycin disk and should be
regarded as resistant to clindamycin. For genotyping, po-
lymerase chain reaction (PCR) was used to detect the cor-





Erythromycin 2.0 to >16.0 8.0 >
Clindamycin <0.016 to >16.0 0.125 >
Cefotaxime <0.016 to 0.125 <0.016
Levofloxacin 0.25e1.0 0.5
MIC Z minimal inhibitory concentration.Results
Antibiotic susceptibility patterns among SDSE
isolates
The antibiogram of 246 SDSE isolates for the six antibiotics
examined is presented in Table 1. All isolates were sus-
ceptible to penicillin, cefotaxime, and vancomycin,
whereas three were resistant to levofloxacin. Rates of
erythromycin and clindamycin resistance reached 24.0%
and 12.2%, respectively. Resistance rates of the isolates
from five hospitals were then compared. We observed a
range from 15.0% to 45.5% for erythromycin, and from 7.1%
to 36.4% for clindamycin (Table 2). The MIC range, MIC50,
and MIC90 of erythromycin-resistant isolates were further
analyzed (Table 3).
Phenotypes and genotypes of erythromycin
resistance
The phenotypes and genotypes of 59 erythromycin-
resistant SDSE isolates were assessed. There were 29
(49.2%), 21 (35.6%), and nine (15.3%) isolates with M,
cMLSB, and iMLSB phenotypes, respectively (Table 4). All
M-type isolates carried mefA. Among the 21 cMLSB isolates,
16 and four isolates carried ermB and ermTR, respectively,
whereas the remaining one possessed both ermB and
ermTR. For the nine iMLSB isolates, five and three isolates
carried ermB and ermTR, respectively, and the remaining
one carried both ermB and ermC. Thus, ermB was found to
be the most common genotype among MLSB-type isolates in
central Taiwan.
Discussion
In this study, all SDSE isolateswere found to be susceptible to
penicillin, cefotaxime, and vancomycin, and most were also
susceptible to levofloxacin. Resistance rates of the isolates
from five hospitals varied significantly for both erythromycin
and clindamycin. Thus, the discrepancy in resistance rates
among hospitals located in central Taiwan desires contin-
uous monitoring. We could only find literatures concerning
antimicrobial susceptibility of GGS, but not SDSE, in Taiwan,
which might partly be owing to the fact that clinical labo-
ratories generally do not perform GGS speciation. Erythro-











Table 4 Phenotypes and genotypes of 59 erythromycin-
resistant isolates
Phenotype Genotype No. Total (%)
cMLSB ermB 16 21 (35.6)
ermTR 4
ermB and ermTR 1
iMLSB ermB 5 9 (15.3)
ermTR 3
ermB and ermC 1
M mefA 29 29 (49.2)
616 H.-H. Lo et al.Streptococcus, group B Streptococcus, and GGS, were
considered to be abnormally high in Taiwan previously.16
After the implementation of a policy restricting erythro-
mycin use in 2001, erythromycin resistance rate in group A
Streptococcus has reduced significantly.19 The erythromycin
resistance rate of GGS in northern Taiwan also declined from
32.6% in 1997 to 23.5% in 2008.15,16 In another report, the
erythromycin resistance rates of non-A,B,D streptococci in a
medical center in northern Taiwan also decreased from
31.7% to 17.9% between 1992 and 2005.20 Recently, we re-
ported that 18.5% of beta-hemolytic group G S. anginosus
group isolates from central Taiwan are resistant to erythro-
mycin.5 Thus, we should pay attention to the fairly high
erythromycin resistance rate of SDSE reported in this study.
Nevertheless, the lack of informative data on erythromycin
resistance rates of SDSE in Taiwan prevents meaningful
comparisons between our results and those from previous
studies, and complicates measures that track changes in
resistance trends in Taiwan.
Phenotypes of 59 erythromycin-resistant SDSE isolates
were resolved, with M type (49.2%) being most dominant.
All M-type isolates carried mefA. For both cMLSB and iMLSB
isolates, the ermB genotype represented the most preva-
lent type, followed by ermTR. Two isolates were carrying
more than one erm genes. Genes encoding erythromycin
resistance determinants in streptococci generally exist in
transposon, plasmid, or prophage.21 Interspecies mobiliza-
tion of an ermT-carrying plasmid from SDSE has recently
been reported.22 The present finding of two isolates with
more than one erm genes may reflect the possible hori-
zontal transfer of erm genes between streptococci in this
area. Studies investigating the prevalence of erythromycin
resistance rates of GGS in Europe revealed a diverse range
of 3.5e33.3%.9,23,24 The most prevalent phenotype and
genotype were iMLSB and ermTR, respectively. Thus, the
erythromycin-resistant trait among GGS in Europe displayed
a considerably different character from SDSE investigated
in this survey. In Asia, a study conducted in Japan focusing
on SDSE reported an erythromycin resistance rate of 10.3%
(15/145).25 Three isolates displayed the iMLSB phenotype
with ermA, five displayed the cMLSB phenotype with ermB,
and the remaining seven displayed the M phenotype with
mefA. Although the resistance rate of SDSE in Japan is much
lower than that in this study, the rates of SDSE with iMLSB
(3/15, 20.0%), cMLSB (5/15, 33.3%), and M (7/15, 46.7%)
phenotypes are unexpectedly similar to our survey.
In conclusion, in this study, the antibiotic susceptibility
pattern and erythromycin resistance mechanisms in beta-hemolytic group G SDSE isolates in central Taiwan were first
resolved. The observed erythromycin resistance rate of
24.0% is relatively high. Both erythromycin and clindamycin
resistance rates of isolates from five hospitals varied
significantly. Mechanisms of erythromycin resistance of
SDSE display similar pattern to that of SDSE in Japan to a
certain extent, but are different from GGS in Europe. The
antibiotic susceptibility should be monitored continuously
in central Taiwan to provide informative data for improving
public health.
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